Terms: = Breast cancer AND SEPT6, RP5-876A24_2, 23157, ENSG00000125354, Q14141, SEP2, MGC16619, KIAA0128, MGC20339
140036 results:
1. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
Montaseri H; Abrahamse H
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
[TBL] [Abstract] [Full Text] [Related]
2. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract] [Full Text] [Related]
3. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
[TBL] [Abstract] [Full Text] [Related]
4. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With breast cancer.
Shaw JA; Page K; Wren E; de Bruin EC; Kalashnikova E; Hastings R; McEwen R; Zhang E; Wadsley M; Acheampong E; Renner D; Gleason KLT; Ambasager B; Stetson D; Fernandez-Garcia D; Guttery D; Allsopp RC; Rodriguez A; Zimmermann B; Sethi H; Aleshin A; Liu MC; Richards C; Stebbing J; Ali S; Rehman F; Cleator S; Kenny L; Ahmed S; Armstrong AC; Coombes RC
JCO Precis Oncol; 2024 Apr; 8():e2300456. PubMed ID: 38691816
[TBL] [Abstract] [Full Text] [Related]
5. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
6. Diffusion probabilistic versus generative adversarial models to reduce contrast agent dose in breast MRI.
Müller-Franzes G; Huck L; Bode M; Nebelung S; Kuhl C; Truhn D; Lemainque T
Eur Radiol Exp; 2024 May; 8(1):53. PubMed ID: 38689178
[TBL] [Abstract] [Full Text] [Related]
7. Multidisciplinary analysis of cancer-related fatigue at the time of diagnosis: preliminary results of the BIOCARE FActory cohort.
Leclercq A; Chatrenet A; Bourgeois H; Cojocarasu O; Mathie C; Martin T; Rahmani A; Morel B
Support Care Cancer; 2024 Apr; 32(5):319. PubMed ID: 38689167
[TBL] [Abstract] [Full Text] [Related]
8. Evolution of neoadjuvant therapy for breast cancer regimens over 12 years and pathologic response rates according to tumor subtypes and clinical stage: A single-center retrospective study.
Li Z; Wang Y
J Cancer Res Ther; 2024 Apr; 20(2):608-614. PubMed ID: 38687931
[TBL] [Abstract] [Full Text] [Related]
9. Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a case-control study of Polish women in Poland and Polish immigrants in USA.
Łukasiewicz-Śmietańska D; Godlewski D; Nowakowska E; Szpak A; Chabros E; Juszczyk G; Charzewska J; Rybaczyk-Pathak D
PLoS One; 2024; 19(4):e0300061. PubMed ID: 38687739
[TBL] [Abstract] [Full Text] [Related]
10. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
11. BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study.
Cozzi A; Pinker K; Hidber A; Zhang T; Bonomo L; Lo Gullo R; Christianson B; Curti M; Rizzo S; Del Grande F; Mann RM; Schiaffino S
Radiology; 2024 Apr; 311(1):e232133. PubMed ID: 38687216
[TBL] [Abstract] [Full Text] [Related]
12. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
[TBL] [Abstract] [Full Text] [Related]
13. Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study.
Mikesell L; O'Malley DM; Kurtzman RT; Howard J; Bates B; Hemler JR; Fadem SJ; Ferrante JM; Bator A; Hudson SV; Crabtree BF
Cancer Med; 2024 May; 13(9):e7219. PubMed ID: 38686635
[TBL] [Abstract] [Full Text] [Related]
14. Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer.
Zhou J; Wan F; Xiao B; Li X; Peng C; Peng FU
Oncol Res; 2024; 32(5):943-953. PubMed ID: 38686052
[TBL] [Abstract] [Full Text] [Related]
15. Neoadjuvant Chemotherapy in Patients with HER2-Negative breast cancer: A Report from Clinical breast cancer Registry of Iran.
Roudini K; Mirzania M; Yavari T; Seyyedsalehi MS; Nahvijou A; Zebardast J; Saadat M; Khajeh-Mehrizi A
Arch Iran Med; 2024 Apr; 27(4):206-215. PubMed ID: 38685847
[TBL] [Abstract] [Full Text] [Related]
16. Association of Neoadjuvant Chemotherapy With Postoperative Outcomes in Immediate Prepectoral Prosthetic breast Reconstruction.
Choi JM; Lee JK; Pyon JK; Mun GH; Jeon BJ; Lee KT
Ann Plast Surg; 2024 May; 92(5):514-521. PubMed ID: 38685491
[TBL] [Abstract] [Full Text] [Related]
17. breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer.
Smith RE; Sprague BL; Henderson LM; Kerlikowske K; Miglioretti DL; Wernli KJ; Onega T; diFlorio-Alexander RM; Tosteson ANA
Breast Cancer Res; 2024 Apr; 26(1):73. PubMed ID: 38685119
[TBL] [Abstract] [Full Text] [Related]
18. Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.
Thonusin C; Osataphan N; Leemasawat K; Nawara W; Sriwichaiin S; Supakham S; Gunaparn S; Apaijai N; Somwangprasert A; Phrommintikul A; Chattipakorn SC; Chattipakorn N
J Transl Med; 2024 Apr; 22(1):398. PubMed ID: 38685030
[TBL] [Abstract] [Full Text] [Related]
19. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis, molecular docking studies and biological evaluation of N-(4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents.
Jorepalli S; Adikay S; Chinthaparthi RR; Gangireddy CSR; Koduru JR; Karri RR
Sci Rep; 2024 Apr; 14(1):9866. PubMed ID: 38684797
[TBL] [Abstract] [Full Text] [Related]
[Next]
